However, most current studies primarily focus on triple-negative breast cancer (TNBC), while systematic insights into the abundance, subset distribution, and functional heterogeneity of MDSCs in Luminal and HER2<sup>+</sup> subtypes remain limited. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.